AbbVie (NYSE:ABBV) shares snapped seven straight sessions of gains, as the stock was down 0.9% at $193.40 on Thursday.
The maker of Humira arthritis therapy added over 12% in the preceding seven sessions. The stock has gained 7.6% so far this year, compared to a